You can search for any reference by title, author, date, editor, journal and publisher. Searching is case insensitive, and allows for only partial terms (e.g. seq with pickup both RNA-Seq and sequencing) matching. You can also use advanced queries that are detailed here.

Entry details

Golegaonkar et al. (2015) "Rifampicin reduces advanced glycation end products and activates DAF-16 to increase lifespan in Caenorhabditis elegans." Aging Cell 14(3):463-473 (PubMed)

Cited by (in linked databases)

  1. Rifampicin demonstrated an avg lifespan change of 42.6 in Caenorhabditis elegans DrugAge
  2. Rifampicin demonstrated an avg lifespan change of 34.8 in Caenorhabditis elegans DrugAge
  3. Rifampicin demonstrated an avg lifespan change of 37.9 in Caenorhabditis elegans DrugAge
  4. Rifampicin demonstrated an avg lifespan change of 43.4 in Caenorhabditis elegans DrugAge
  5. Rifampicin demonstrated an avg lifespan change of 49.2 in Caenorhabditis elegans DrugAge
  6. Rifampicin demonstrated an avg lifespan change of 45.3 in Caenorhabditis elegans DrugAge
  7. Rifampicin demonstrated an avg lifespan change of 50.8 in Caenorhabditis elegans DrugAge
  8. Rifampicin demonstrated an avg lifespan change of 55.8 in Caenorhabditis elegans DrugAge
  9. Rifampicin demonstrated an avg lifespan change of 45.4 in Caenorhabditis elegans DrugAge
  10. Rifampicin demonstrated an avg lifespan change of 56.1 in Caenorhabditis elegans DrugAge
  11. Rifamycin SV demonstrated an avg lifespan change of 20.9 in Caenorhabditis elegans DrugAge

Tagged with